Changes in Sensitization Patterns in the Last 25 Years in 619 Patients with Confirmed Diagnoses of Immediate Hypersensitivity Reactions to Beta-Lactams
María del Valle Campanón Toro,
Esther Moreno Rodilla,
Alicia Gallardo Higueras,
Elena Laffond Yges,
Francisco J. Muñoz Bellido,
María Teresa Gracia Bara,
Cristina Martin García,
Vidal Moreno Rodilla,
Eva M. Macías Iglesias,
Sonia Arriba Méndez,
Miriam Sobrino García,
Ignacio Dávila
Affiliations
María del Valle Campanón Toro
Allergy Service, University Hospital of Salamanca, 37007 Salamanca, Spain
Esther Moreno Rodilla
Allergy Service, University Hospital of Salamanca, 37007 Salamanca, Spain
Alicia Gallardo Higueras
Allergy Service, University Hospital of Salamanca, 37007 Salamanca, Spain
Elena Laffond Yges
Allergy Service, University Hospital of Salamanca, 37007 Salamanca, Spain
Francisco J. Muñoz Bellido
Allergy Service, University Hospital of Salamanca, 37007 Salamanca, Spain
María Teresa Gracia Bara
Allergy Service, University Hospital of Salamanca, 37007 Salamanca, Spain
Cristina Martin García
Allergy Service, University Hospital of Salamanca, 37007 Salamanca, Spain
Vidal Moreno Rodilla
Department of Computer Science and Automatic, University of Salamanca, 37008 Salamanca, Spain
Eva M. Macías Iglesias
Allergy Service, University Hospital of Salamanca, 37007 Salamanca, Spain
Sonia Arriba Méndez
Allergy Service, University Hospital of Salamanca, 37007 Salamanca, Spain
Miriam Sobrino García
Allergy Service, University Hospital of Salamanca, 37007 Salamanca, Spain
Ignacio Dávila
Allergy Service, University Hospital of Salamanca, 37007 Salamanca, Spain
Beta-lactam (BL) drugs are the antibiotics most prescribed worldwide due to their broad spectrum of action. They are also the most frequently implied in hypersensitivity reactions with a known specific immunological mechanism. Since the commercialization of benzylpenicillin, allergic reactions have been described; over the years, other new BL drugs provided alternative treatments to penicillin, and amoxicillin is now the most prescribed BL in Europe. Diagnosis of BL allergy is mainly based on skin tests and drug provocation tests, defining different sensitization patterns or phenotypes. In this study, we evaluated 619 patients with a confirmed diagnosis of BL-immediate allergy during the last 25 years, using the same diagnostic procedures with minor adaptations to the successive guidelines. The initial eliciting drug was benzylpenicillin, which changed to amoxicillin with or without clavulanic acid and cephalosporins in recent years. In skin tests, we found a decrease in sensitivity to major and minor penicillin determinants and an increase in sensitivity to amoxicillin and others; this might reflect that the changes in prescription could have influenced the sensitization patterns, thus increasing the incidence of specific reactions to side-chain selective reactions.